These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of L-dopa holiday in the long-term management of Parkinson's disease. Kaye JA; Feldman RG Clin Neuropharmacol; 1986; 9(1):1-13. PubMed ID: 3548951 [No Abstract] [Full Text] [Related]
3. [The results of drug holiday in Parkinson's disease]. Martínez F; Castillo J; Castro A; Lema M; Noya M Neurologia; 1992 Nov; 7(9):254-9. PubMed ID: 1445710 [TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of the effects of an L-dopa drug holiday on the course of Parkinson's disease. Corona T; Rivera C; Otero E; Stopp L Clin Neuropharmacol; 1995 Aug; 18(4):325-32. PubMed ID: 8665545 [TBL] [Abstract][Full Text] [Related]
5. Reappraisal of temporary levodopa withdrawal ("drug holiday") in Parkinson's disease. Mayeux R; Stern Y; Mulvey K; Cote L N Engl J Med; 1985 Sep; 313(12):724-8. PubMed ID: 4033697 [TBL] [Abstract][Full Text] [Related]
6. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study. Svenningsson P; Rosenblad C; Af Edholm Arvidsson K; Wictorin K; Keywood C; Shankar B; Lowe DA; Björklund A; Widner H Brain; 2015 Apr; 138(Pt 4):963-73. PubMed ID: 25669730 [TBL] [Abstract][Full Text] [Related]
7. 'Drug holidays' in the treatment of Parkinson's disease. A brief review. Friedman JH Arch Intern Med; 1985 May; 145(5):913-5. PubMed ID: 3888135 [TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease]. Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079 [TBL] [Abstract][Full Text] [Related]
11. Drug holiday and management of Parkinson disease. Weiner WJ; Koller WC; Perlik S; Nausieda PA; Klawans HL Neurology; 1980 Dec; 30(12):1257-61. PubMed ID: 7192805 [TBL] [Abstract][Full Text] [Related]
12. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom. Lees AJ BMJ; 1995 Dec; 311(7020):1602-7. PubMed ID: 8555803 [TBL] [Abstract][Full Text] [Related]
13. Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients. Kumar R; Hauser RA; Mostillo J; Dronamraju N; Graf A; Merschhemke M; Kenney C Int J Neurosci; 2016; 126(1):20-4. PubMed ID: 24007304 [TBL] [Abstract][Full Text] [Related]
14. [Usefulness of drug holiday in patients with Parkinson's disease of more than 5 years of development]. Corona T; Rivera Nava C; Reyes Báez B; Carbajal A Rev Invest Clin; 1991; 43(4):334-7. PubMed ID: 1798867 [TBL] [Abstract][Full Text] [Related]
15. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease. Koziorowski D; Friedman A Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308 [TBL] [Abstract][Full Text] [Related]